USE

Jonathan Milner calls Extraordinary General Meeting to restore focus to Abcam on governance, execution, and cost control

Retrieved on: 
Tuesday, May 30, 2023

SUBJECT TO THE FOREGOING, AND AS SET FORTH BELOW, DR. MILNER INTENDS TO MAKE AVAILABLE AT AN APPROPRIATE TIME ADDITIONAL INFORMATION ABOUT THE EXTRAORDINARY GENERAL MEETING INCLUDING HOW TO VOTE AT SUCH MEETING.

Key Points: 
  • SUBJECT TO THE FOREGOING, AND AS SET FORTH BELOW, DR. MILNER INTENDS TO MAKE AVAILABLE AT AN APPROPRIATE TIME ADDITIONAL INFORMATION ABOUT THE EXTRAORDINARY GENERAL MEETING INCLUDING HOW TO VOTE AT SUCH MEETING.
  • DR. MILNER HAS INVESTMENTS IN ABCAM PLC (THE “COMPANY”), AND CONSEQUENTLY HAS A FINANCIAL INTEREST IN THE PROFITABILITY OF HIS POSITIONS IN THE COMPANY.
  • DR. MILNER IS NOT RESPONSIBLE TO ANY PERSON FOR PROVIDING ADVICE IN RELATION TO THE SUBJECT MATTER OF THIS DOCUMENT.
  • DR. MILNER HAS NOT SOUGHT OR OBTAINED CONSENT FROM ANY THIRD PARTY TO USE ANY STATEMENTS OR INFORMATION CONTAINED HEREIN.

Terran Biosciences announces new breakthroughs in the chemistry of MDMA and its enantiomers and analogs, discovers new salts and polymorphs, publishes PCT application.

Retrieved on: 
Friday, May 26, 2023

MDMA is the most studied empathogen to date and has been shown to be an effective treatment for post-traumatic stress disorder (PTSD) in multiple phase 3 trials.

Key Points: 
  • MDMA is the most studied empathogen to date and has been shown to be an effective treatment for post-traumatic stress disorder (PTSD) in multiple phase 3 trials.
  • Historically, MDMA has only been developed as a single salt and the crystal structures of its enantiomers had not been characterized.
  • As previously reported, Terran found that the S enantiomer of MDEA had significant advantages over the (R)-MDEA in preclinical models.
  • Terran is also developing the S enantiomer of MBDB which was shown to have significant advantages over (R)-MBDB in preclinical models.

MSCI Equity Indexes May 2023 Index Review

Retrieved on: 
Thursday, May 11, 2023

MSCI Inc. (NYSE:MSCI), a leading provider of critical decision support tools and services for the global investment community, announced the results of the May 2023 Index Review for the MSCI Equity Indexes - including the MSCI Global Standard, MSCI Global Small Cap and MSCI Micro Cap Indexes, the MSCI Global Value and Growth Indexes, the MSCI Frontier Markets, and MSCI Frontier Markets Small Cap Indexes, the MSCI Global Islamic and MSCI Global Islamic Small Cap Indexes, the MSCI US Equity Indexes, the MSCI US REIT Index, the MSCI China A Onshore indexes and the MSCI China All Shares Indexes.

Key Points: 
  • MSCI Inc. (NYSE:MSCI), a leading provider of critical decision support tools and services for the global investment community, announced the results of the May 2023 Index Review for the MSCI Equity Indexes - including the MSCI Global Standard, MSCI Global Small Cap and MSCI Micro Cap Indexes, the MSCI Global Value and Growth Indexes, the MSCI Frontier Markets, and MSCI Frontier Markets Small Cap Indexes, the MSCI Global Islamic and MSCI Global Islamic Small Cap Indexes, the MSCI US Equity Indexes, the MSCI US REIT Index, the MSCI China A Onshore indexes and the MSCI China All Shares Indexes.
  • In light of currently observed market accessibility issues, MSCI will not implement changes as part of this Index Review for any securities classified in Bangladesh, Egypt, Kenya, Nigeria, or Sri Lanka for the MSCI Bangladesh, MSCI Egypt, MSCI Kenya, MSCI Nigeria, and MSCI Sri Lanka Indexes or impacted composite indexes.
  • MSCI US Equity Indexes: There will be eight securities added to and four securities deleted from the MSCI US Large Cap 300 Index.
  • Accordingly, constituents in MSCI equity indexes may include MSCI Inc., clients of MSCI or suppliers to MSCI.

Terran Biosciences announces publication of four PCT patent applications covering breakthroughs in novel empathogens, including improved versions of methylone, ethylone, MDEA, MDAI, and MBDB

Retrieved on: 
Thursday, May 11, 2023

The discoveries include novel deuterated forms, enantiomerically pure forms, as well as novel salts, polymorphs, and co-crystals of racemic methylone, R-methylone and S-methylone.

Key Points: 
  • The discoveries include novel deuterated forms, enantiomerically pure forms, as well as novel salts, polymorphs, and co-crystals of racemic methylone, R-methylone and S-methylone.
  • Terran believes that therapeutic options for patients should be equally diverse, with unique psychedelics and empathogens tailored to specific patient needs.
  • Terran completed what is believed to be the first comprehensive salt and polymorph screen performed to date on this compound.
  • Terran completed additional improvements including the synthesis of deuterated forms of racemic methylone, R-methylone, and S-methylone with improved pharmacokinetics.

Clarion Partners Real Estate Income Fund Inc. (CPREIF) Announces Tender Offer

Retrieved on: 
Thursday, May 11, 2023

The tender offer will be conducted at a price equal to the Fund’s NAV per share of common stock on the day on which the tender offer expires.

Key Points: 
  • The tender offer will be conducted at a price equal to the Fund’s NAV per share of common stock on the day on which the tender offer expires.
  • The Fund intends to commence its tender offer on or about June 13, 2023, with the expiration of the tender offer currently expected to be July 14, 2023.
  • The tender offer will be made only by an Offer to Purchase, a Repurchase Request Form, and related documents.
  • As soon as the tender offer commences, the Fund will file a tender offer statement on Schedule TO with the SEC, which will include an Offer to Purchase and related Repurchase Request Form.

XAI Octagon Floating Rate & Alternative Income Term Trust Will Host Q1 2023 Quarterly Webinar on May 25, 2023

Retrieved on: 
Tuesday, May 9, 2023

XAI Octagon Floating Rate & Alternative Income Term Trust (NYSE: XFLT) (the “Trust”) today announced that it plans to host the Trust’s Quarterly Webinar on May 25, 2023 at 12:00 pm (Eastern Time).

Key Points: 
  • XAI Octagon Floating Rate & Alternative Income Term Trust (NYSE: XFLT) (the “Trust”) today announced that it plans to host the Trust’s Quarterly Webinar on May 25, 2023 at 12:00 pm (Eastern Time).
  • Kimberly Flynn, Managing Director at XA Investments (“XAI”) will moderate the Q&A style webinar with Steven Perry, Vice President at XAI, and Gretchen Lam, Senior Portfolio Manager at Octagon Credit Investors.
  • The investment objective of the Trust is to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle.
  • Under normal market conditions, the Trust will invest at least 80% of its Managed Assets in floating rate credit instruments and other structured credit investments.

Clarion Partners Real Estate Income Fund Inc. Announces Funds from Operations

Retrieved on: 
Tuesday, May 9, 2023

Clarion Partners Real Estate Income Fund Inc. (the “Fund”) has announced funds from operations (“FFO”), adjusted funds from operations and funds available for distribution for the period of January 1, 2023 to March 31, 2023.

Key Points: 
  • Clarion Partners Real Estate Income Fund Inc. (the “Fund”) has announced funds from operations (“FFO”), adjusted funds from operations and funds available for distribution for the period of January 1, 2023 to March 31, 2023.
  • FFO is a standard real estate investment trust (“REIT”) industry metric defined by the National Association of Real Estate Investment Trusts (“NAREIT”).
  • The Fund also believes that adjusted FFO (“AFFO”) is a meaningful non-GAAP supplemental disclosure of its operating results.
  • The Fund’s investment manager, Legg Mason Partners Fund Advisor, LLC, is an indirect, wholly-owned subsidiary of Franklin Resources, Inc. (“Franklin Resources”) and the Fund’s investment sub-adviser, Clarion Partners, LLC (“Clarion Partners”), is an indirect, majority-owned subsidiary of Franklin Resources.

MSCI May Index Review Announcement Scheduled for May 11, 2023

Retrieved on: 
Thursday, May 4, 2023

MSCI Inc. (NYSE:MSCI), a leading provider of critical decision support tools and services for the global investment community, will announce the results of the May 2023 Index Review for the MSCI Equity Indexes - including the MSCI Global Standard, MSCI Global Small Cap and MSCI Micro Cap Indexes, the MSCI Global Value and Growth Indexes, the MSCI Frontier Markets, and MSCI Frontier Markets Small Cap Indexes, the MSCI Global Islamic and MSCI Global Islamic Small Cap Indexes, the MSCI Pan-Euro and MSCI Euro Indexes, the MSCI US Equity Indexes, the MSCI US REIT Index, the MSCI China A Onshore indexes and the MSCI China All Shares Indexes.

Key Points: 
  • MSCI Inc. (NYSE:MSCI), a leading provider of critical decision support tools and services for the global investment community, will announce the results of the May 2023 Index Review for the MSCI Equity Indexes - including the MSCI Global Standard, MSCI Global Small Cap and MSCI Micro Cap Indexes, the MSCI Global Value and Growth Indexes, the MSCI Frontier Markets, and MSCI Frontier Markets Small Cap Indexes, the MSCI Global Islamic and MSCI Global Islamic Small Cap Indexes, the MSCI Pan-Euro and MSCI Euro Indexes, the MSCI US Equity Indexes, the MSCI US REIT Index, the MSCI China A Onshore indexes and the MSCI China All Shares Indexes.
  • Clients can access the subscriber section of each index at: www.msci.com/index-review-subscribers
    For the MSCI US Equity Indexes and the MSCI US REIT Index, a summary of the announcement will be made available at www.msci.com .
  • Accordingly, constituents in MSCI equity indexes may include MSCI Inc., clients of MSCI or suppliers to MSCI.
  • MSCI ESG and climate ratings, research and data are produced by MSCI ESG Research LLC, a subsidiary of MSCI Inc. MSCI ESG Indexes, Analytics and Real Estate are products of MSCI Inc. that utilize information from MSCI ESG Research LLC.

Clarion Partners Real Estate Income Fund Inc. Announces Results of Tender Offer

Retrieved on: 
Wednesday, April 19, 2023

The Fund transmitted payment to purchase the duly tendered and accepted Shares on April 18, 2023.

Key Points: 
  • The Fund transmitted payment to purchase the duly tendered and accepted Shares on April 18, 2023.
  • Shares that were tendered but not accepted for payment, if applicable, and Shares that were not tendered will remain outstanding.
  • Any questions about the tender offer should be directed to SS&C Global Investor & Distribution Solutions, Inc. (formerly SS&C Technologies, Inc.), the Information Agent for the tender offer, toll free at (844) 534-4627.
  • THIS PRESS RELEASE IS NOT A PROSPECTUS, CIRCULAR OR REPRESENTATION INTENDED FOR USE IN THE PURCHASE OR SALE OF FUND SHARES.

Bilt Rewards Teams Up with Lyft: Bilt Members and Cardholders Can Now Earn Up to 5x Bilt Points On Rideshare Trips Booked Through the Lyft App

Retrieved on: 
Wednesday, March 8, 2023

NEW YORK, March 8, 2023 /PRNewswire/ -- Bilt Rewards, the leading loyalty program for renters, and Lyft, one of the largest transportation networks in the U.S. and Canada, today announce a partnership that will enable Bilt members to start earning accelerated Bilt Points when booking rides through the Lyft app. This marks a new way for Bilt loyalty members and Bilt Mastercard® cardholders to earn additional Bilt Points on their everyday expenses.

Key Points: 
  • Starting today, Bilt loyalty members and Bilt Mastercard cardholders can now earn Bilt Points on their Lyft rides.
  • Now with the ability to earn extra Bilt Points, Bilt Rewards and Lyft are making your next ride even more rewarding.
  • To start earning up to 5x Bilt Points on Lyft rides, Bilt members and cardholders can link their Bilt Rewards and Lyft accounts directly in the Bilt Rewards app.
  • Once linked, members will enjoy:
    2X POINTS FOR LOYALTY MEMBERS: Earn 2x Bilt Points on Lyft rideshare when you link your Bilt Rewards and Lyft accounts.